ClearPoint Neuro, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Oct 28, 2026 (2 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 18, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Mar 18, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Mar 5, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Apr 25, 2025 | B. Riley Securities | maintain | Buy → Buy | $28 | 54% |
| Apr 1, 2025 | Stifel | maintain | Buy → Buy | $25 | 53% |
| Jan 28, 2025 | B. Riley Securities | maintain | Buy → Buy | $20 | 54% |
| Jan 21, 2025 | Lake Street | maintain | Buy → Buy | $30 | 47% |
| Aug 27, 2024 | Lake Street | maintain | Buy → Buy | $15 | 47% |
| Mar 13, 2024 | Stifel | reiterate | Buy → Buy | $9 | 53% |
| Oct 24, 2023 | Stifel | initiate | — → Buy | $8 | 53% |
| Aug 9, 2023 | Lake Street | maintain | Buy → Buy | $15 | 47% |
| Mar 18, 2021 | Lake Street | initiate | — → Buy | $32 | 47% |
| Jul 17, 2020 | B. Riley Securities | initiate | — → Buy | $8 | 54% |
No cross-platform signals in the last 90 days